Cardiac rehabilitation (CR) is reported as effective program to improve coronary risk factors and increase exercise tolerance in patients with coronary artery disease (CAD) after cardiac events. Normally, the CR program is performed in 3 phases i.e. acute (phase I), subacute (phase II), and chronic (phase III). In Indonesia, the most CR programs were conducted using phase I and some phase II, whereas phase III CR program has not often been performed due to it is not covered by national health insurance. The aim of the study was to evaluate the effects of phase III comprehensive CR program on physical status and coronary risk factors among CAD patients. Seventy-four patients were stratified as the intervention group (n=37) and the control group (n=37). In the intervention group, patients participated in an hospital-based phase III CR program for 6 months, whereas in the control group, patients received a standard care. The CR program consists of warm-up, aerobic exercise, cool-down stretching, and health education session three days a week. Blood glucose level and lipid profile examinations were performed before and sixth month after the program implemented to assess patient's metabolic status. Among 74 patients involved in this study, most patients were male (85.1%) with mean age 54.7±3.4 years old. Fifty-seven patients had post-procedural history (77% post-PCI, 4% post-CABG), 8 patients (11%) were still active smokers, 31 patients (42%) had diabetes, and 60 patients (81%) had hypertension. Participation in the hospital-based phase III CR program was significantly correlated with lower low-density lipoprotein (LDL) level (p=0.003; r=0.41), triglyceride level (p=0.001; r=0.38), and fasting blood glucose level (p<0.001; r=0.46) during 6-month follow up. In conclusion, patients with CAD who undergo hospital-based phase III CR program have significantly better fasting glucose control, LDL, and triglyceride levels. These results may encourage other hospitals to perform the same program achieving better prognosis of CAD patients.
INTRODUCTION
Cardiovascular diseases (CVDs) are the leading cause of death globally. It is estimated 7.4 million deaths per year due to ischemic heart disease. 1 Indonesian National Health Survey (RISKESDAS) in 2013 placed cardiac-cerebro-vascular disease as the top rank of cause of death in Indonesia. 2 These catastrophic diseases are known as noncommunicable and preventable diseases. Establishing a preventive strategy, numerous studies were conducted in multicenter worldwide, in order to determine the efficacy of physical activity in reducing cardiovascular (CV) mortality. Anderson et al. 3 demonstrated the importance of cardiac rehabilitation (CR) in coronary arterydisease (CAD) patients after cardiac events. This study revealed the significant benefits of CR to decrease total mortality, myocardial infarction, and revascularization. Moreover, CR could improve coronary risk factors, provide costeffectiveness as secondary CVD prevention, and increase quality of life (QoL) and exercise tolerance. [3] [4] [5] In general, CR programs are performed in three main stages: acute stage (phase I), subacute stage (phase II), and chronic stage (phase III). [6] [7] [8] Phase I CR starts immediately from the first day of patient admission in hospital. Phase II CR exists in a multidisciplinary program requiring a series of knowledge and skills to bring together medical treatment, risk factor control, education, exercise training, and counseling for all people with CAD. Afterward, maintaining what have been done in phase II in community is the main part of phase III CR program. 7, 8 In Indonesia, most cardiac rehabilitation programs have been phase I and some phase II, whereas phase III CR has not often been performed since it was not covered by National Health Insurance yet. 9 Therefore, limited data are available regarding the effects of phase III cardiac rehabilitation on metabolic status, particularly in local population.
This study aimed to assess the beneficial effects of 6-month hospital-based phase III CR program on physical status and coronary risk factors among CAD patients.
MATERIALS AND METHODS

Subjects
During January-June 2016, we retrospectively enrolled 74 consecutive patients in cardiology outpatient clinic who were more than 40 years old. The all patients had been referred at least 6 months after a major coronary event, such as acute myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention (PCI). Thirty-seven patients who consistently (>90% attendance) attending in a phase III CR program at Pupuk Kaltim Hospital were categorized as intervention group. Thirtyseven other patients who did not join in phase III CR program were categorized as control group. Patients with on going congestive heart failure, liver dysfunction (aspartate amino transferase ≥40 IU/L), renal dysfunction (creatinine ≥2.0 mg/dL), or systemic diseases (malignancy and collagen disease) were excluded.
Protocols
Entire subjects were directed for blood sample work up in order to have base line of metabolic parameters, comprise of body mass index (BMI), blood pressure, lipid profile (low-density lipoprotein/LDL, highdensity lipoprotein/HDL, total cholesterol and triglycerides), blood glucose profile (fasting and 2 hours post prandial blood glucose levels) in 0 and 6 months observation. These laboratory parameters were determined in Pupuk Kaltim Hospital laboratories using direct measurement by homogenous assay of COBAS INTEGRA 400 plus analyzer.
In the intervention group, subjects participated in a hospital-based phase III CR program, while the control group received usual outpatient care, including monthly medical examination by the physician in charge. Phase III CR program consists of warm-up (senam jantung sehat) for 10 minutes, aerobic exercise for the next 40 minutes, cool-down stretching for last 10 minutes, and health education session three days a week. Blood pressure and heart rate were monitored during the program and in outpatient clinic. Laboratory measurements were performed at the beginning and sixth month to assess patient's metabolic status.
Except for the rehabilitation protocol, standard medical care was provided for both groups. Lipid-lowering drugs (simvastatin or atorvastatin 20 mg) that may affect lipid levels were given at stable doses for at least 4 weeks before entry, and the doses of these medications were not altered during the study period). The Research Ethics Committee of Pupuk Kaltim Hospital approved the protocol. All subjects received full verbal and written explanations of the nature and purpose of the study, and each gave written informed consent.
Data analysis
The data analysis was conducted using SPPS version 22.0. All numeric outcomes were analyzed for Kolmogorov-Smirnov test, a test of normality. We used unpaired t-test (for normal distributed variables) or Mann-Whitney test (for abnormal distributed variables) to compare means between groups. Moreover, multivariate analysis was performed using multivariate analysis of variance test.
RESULTS
Among 74 patients involved in this study, most patients were over 50 years old and male dominant (81% in CR group and 89% in non-CR group, 85% of overall subjects). Mean of BMI in CR group was 26. 9 After 6 months observation in CR and non-CR group, several metabolic parameters via laboratory examination revealed some changes in terms of fasting blood levels, 2 hours post prandial blood glucose level and lipid profile (LDL, HDL, total cholesterol and triglycerides levels) if compared 0 month of baseline data. In non-CR group, grossly the data showed worsening of metabolic status compared to baseline. In contrary, the trends on reduction of those metabolic parameters were observed in CR groups (TABLE 2). 
DISCUSSION
This research population were observed as homogenous in intervention and nonintervention group. The results presented statistically significant reduction of fasting blood glucose (p<0.001), LDL cholesterol (p<0.003) and triglycerides (p=0.001) in phase III CR group than non-CR group. Since, one of the main pillars of CR is exercise training, mainly dynamic and aerobic exercise have been related with increased of cardiorespiratory fitness.
10,11 Bauer et al. 12 have demonstrated exercise training improves glucose metabolism, insulin signalling, lipid profile, endothelial function, and blood pressure as well as exercise tolerance, in both diabetic and non-diabetic patients. However, in diabetic patients these parameters were remarkably improved. Hindman et al. 13 reported declining of FBG and blood lipid profile in diabetic patients who participated in a CR program after the onset of MI. Similarly, our study showed improved glucose metabolism and lipid metabolism, especially LDL-C and triglycerides with continued hospital-based phase III CR after cardiac events. The basic mechanism of physical exercise in controlling blood glucose and lipid levels are consist of improvement of insulin sensitivity, by increases the activity of AMP-dependent protein kinase (AMPK), thereby stimulating the uptake and metabolism of glucose and lipids in skeletal muscles.
14 These changes can be seen starting from acute phase of exercise (1-2 hours) to the chronic phase of exercise program. Abolishment of musclin expression and increment in expression of GLUT4 were also observed in physical activity to improve insulin resistance. 15 Analysis of lipid profile in our study confirmed the previous investigations. A significant decrease in total cholesterol and triglycerides was also reported by other authors. 5 It was found that low-intensity and moderate exercise induces an increase in HDL and decreases triglycerides in healthy subjects. However, reduction of total cholesterol is not always detectable. 16 Similarly, we did not get a significant reduction of total cholesterol. However, a significant decline of LDL-C and triglyceride were observed. Other investigation was conducted, only triglyceride were significantly decreased after 12 and 24 weeks of CR in CAD patients. 17 J-CARP trial in Japan, 18 firmly consistent with our study, it stated not only greater enhancement lipid prolife but decrement of BMI, fat mass and Apo-AI were perceived. Magkos et al. 19 reported a prolonged moderate-intensity aerobic exercise augments the clearance rate of very low density lipoprotein-triglyceride (VLDL-TG) from plasma by enhancing the efficiency of VLDL-TG removal from the circulation, without affecting VLDL-TG secretion by the liver. This augmentation of clearance rate of VLDL-TG from plasma is the main reason why triglycerides significantly reduced in 6 months patients who undergoing phase III CR program.
Phase III CR program yielded LDL-C levels enhancements with statically significant and moderate positive correlation. Mean LDL-C reduction after 6 months CR program is 6.7 mg/dL. The previous study revealed a 1.7% reduction in major coronary events occurred with each 1% lowering of LDL-C in CAD patient subjects. 20 Notwithstanding, based on ESC guideline of dyslipidemia 21 risk stratification, our subjects are categorized as very high risk patients. The target of LDL-C in very high risk population is below 70 mg/ dL, 21, 22 which means the target of LDL-C levels in our study were not yet achieved. Yet, the average improvement of LDL-C levels in our population reached 5% of reduction. Thus, we realized that the phase III CR program is the key component toward LDL-C target despite of optimal lipid-lowering medications. Moreover, in this study, we observed that there were no significant differences between groups in terms of statin therapy prior to the intervention.
Stevens et al. 23 established the effects of fitness were somewhat more consistent than the effects of fatness. Hence, the best way to reduce the risk of mortality, fit persons need to attain or maintain a normal body weight, and normal weight persons need to attain or maintain at least a moderate level of fitness. And, the finest approach to be fit is having moderate intensity aerobic exercise regularly, 150 minutes/weeks. 24 Particularly in patients after cardiac event, continuing cardiac rehabilitation program in community levels is the leading way to be fit.
CONCLUSION
This study proves that patients with CAD who underwent hospital-based phase III CR program has significantly better fasting glucose control, LDL, and triglyceride level during 6-month follow up. Although this study is the first study that attempt to explore the role of phase III CR program in post myocardial infarction patients in Indonesia, we still need a larger number of subjects that represent multi ethnicity of general population. Therefore, we strongly recommend further multicenter team works to carry out the importance of phase III CR program in metabolic improvement, so that phase III CR program can be delivered in many centers in Indonesia and covered by national insurance program. This will lead to better prognosis of future cardiac events and quality of life among CAD patients.
